Mark is an Investment Director with over 18 years’ venture capital experience, with particular expertise in the life science sector. He has been involved in all aspects of creating venture backed businesses, including sourcing new opportunities, working with founders and management teams to build valuable propositions, through to public market listings and trade sales. He has been a non-executive director of several private and public companies. Mark has worked across several early-stage venture funds, including the RisingStars Growth Funds, the North West Fund for Venture Capital, Finance Yorkshire Seedcorm Fund, and is actively looking for new life science deals for the Northern Powerhouse Fund. He has been heavily involved in the following investments; Concepta plc, Evgen and Abingdon Healthcare.
Mark is a member of the Mercia Responsible Investment Committee – a Group-wide team committed to delivering the ESG strategy across the business.
Mark spent two years as bioscience ventures manager at London-based Imperial Innovations. Prior to joining Imperial, Mark had spent the previous five years with Mercia’s technology team based in the North West, and before that, six years at Merlin Biosciences, a venture capital and advisory company dedicated to the life sciences sector.